Dr. Anupama Poliyedath, MD

Dr. Poliyedath practices at Saint Agnes Care in Fresno, California.

Dr. Poliyedath's NPI, 1548317126, was assigned on January 4, 2007. Dr. Poliyedath graduated from All India Institute of Medical Sciences in 2000. Dr. Poliyedath holds California license C55333.

Dr. Poliyedath's primary practice is Saint Agnes Care, at 1379 E Herndon Ave, Fresno, CA 93720 in Fresno County. The practice phone is (559) 450-5611.

Dr. Poliyedath's primary practice is Saint Agnes Care in Fresno, California. Dr. Poliyedath is also affiliated with Saint Agnes Medical Center. The medical group on file is Saint Agnes Care. Dmand AI also links Dr. Poliyedath to 1 more hospital, 3 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Poliyedath practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Poliyedath's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Poliyedath is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Poliyedath's licenses on file in 3 states: California, New Hampshire and Illinois.

Dmand AI lists acid reflux, acute respiratory failure, acute sinusitis, anxiety, arthritis, asthma, atrial fibrillation and flutter and bipolar disorder among the conditions Dr. Poliyedath treats.

CMS data shows 1,270 Medicare services from Dr. Poliyedath across 19 procedure codes in 2024, for 346 Medicare patients. Medicare paid $82,226 for them.

CMS counts 346 Medicare patients who saw Dr. Poliyedath in 2024. The largest group is 65 to 74, with 147 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 49% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Poliyedath's median patient age at 62, with 59% women.

In 2024, Dr. Poliyedath wrote 2,412 Medicare Part D claims for 312 patients. 86% of them were for generic drugs. CMS names the drug for 1,874 of them, across 61 drugs with 11 or more claims each, at $141,776 in total drug cost. In 2023, CMS named 1,928 claims across 61 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Poliyedath for performance year 2024, reported individually. Dr. Poliyedath accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Poliyedath as offering telehealth.

Dmand AI links 3 papers to Dr. Poliyedath, published from 2016 to 2022. Dr. Poliyedath's most frequent co-authors are Soe Naing, MD, Yudhveer Brar, MD and Jasmine Kaur Garcha.

CMS Open Payments shows 21 general payments to Dr. Poliyedath from 14 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 84% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $2,737.

Dmand AI lists 3 awards for Dr. Poliyedath, most recently CMS Stage 1 EHR in 2013.

Dr. Poliyedath graduated from All India Institute of Medical Sciences in 2000.

Dr. Poliyedath is in network with 15 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.